About Sterixia
Sterixia was founded by a former U.S. Navy submariner who spent 20 years operating and ultimately commanding a nuclear-powered submarine — responsible for reactor-plant operations, engineering, crew training, and maintenance. In that environment, procedural rigor, traceability, and quality assurance aren’t ideals; they’re survival. Sterixia applies that same regulated-industry discipline to high-purity oil refinement and excipient production. Every batch, every test, and every document follows the principles of precision, control, and verified performance.
Sterixia provides formulation labs and manufacturers with dependable access to high-purity oils and solvents — backed by documentation, consistency, and U.S.-based fulfillment.
Our mission is to deliver transparent, reproducible, high-performing ingredients for cosmetic development, formulation R&D, and small-batch production.
Our Mission
Our mission is simple: provide labs with clean, documented, and reliable ingredients they can trust.
We prioritize traceability, scientific rigor, and documentation-first standards so every lot performs exactly as expected — whether it’s used in cosmetics, R&D, peptides, or formulation workflows.
• 3 Launch SKUs
High-purity oils and solvents ready for formulation work.
• Documentation-First
CoA, FTIR identity, physical & chemical testing on every batch.
• U.S.-Based Fulfillment
Predictable delivery with maintained local inventory.
Our Future Roadmap
While Sterixia’s 2026 focus is on high-purity oils and solvents, our long-term roadmap expands into advanced formulation ingredients and sterile excipient capabilities. Supporting tomorrow’s pharmaceutical and formulation standards is central to our vision.
2026 — Launch of high-purity oils & solvents
2027 — Expanded cosmetic & lab ingredient portfolio
2028–2029 — Sterile excipients & deeper vertical integration